Health Care: Drugs

Anthera Pharmaceuticals Inc (ANTH: NASDAQ)

$3.05 -0.01 | -0.33%
07/25/14 - 02:25 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 6.56M 6.72M 7.86M 6.30M
Research & Development 21.68M 49.22M 85.28M 29.46M
Operating Income before D & A (EBITDA) -28.25M -55.93M -93.14M -35.76M
Depreciation & Amortization 1.52M 1.20M 902.00K 888.34K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -15.00K -111.00K 606.00K -3.80M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -29.78M -57.25M -93.43M -40.44M
Interest Expense 2.60M 3.35M 2.80M 859.73K
Pre-Tax Income -32.38M -60.60M -96.24M -41.30M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -30.86M -59.40M -95.34M -40.41M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -30.86M -59.40M -95.34M -40.41M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -30.86M -59.40M -95.34M -40.41M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-30.86M -59.40M -95.34M -40.41M
Preferred Dividends
Net Income Available To Common -30.86M -59.40M -95.34M -40.41M
Basic EPS from Continuing Ops. -1.69 -8.22 -20.38 -14.11
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.69 -8.22 -20.38 -14.11
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.02 -0.02 0.03
Basic EPS, Total -1.69 -8.24 -20.40 -14.08
Basic Normalized Net Income/Share -1.69 -8.22 -20.38 -14.11
EPS fr Continuing Ops. -1.69 -8.22 -20.38 -14.11
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.69 -8.22 -20.38 -14.11
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.02 -0.02 0.03
EPS, Total -1.69 -8.24 -20.40 -14.08
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.69 -8.22 -20.38 -14.11
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ANTH

Latest ANTH Headlines from TheStreet

More Financial News for ANTH

Press Releases for ANTH

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter